ÂÜÀòÂÒÂ×

Cory Fiset currently serves as Senior Director of Corporate Finance at Alnylam Pharmaceuticals, a position held since September 2024. Prior to this role, Cory held various senior finance positions at Akebia Therapeutics, including Senior Director and Director of Corporate Finance from July 2020 to September 2024. Cory's experience also includes leadership roles at Intarcia Therapeutics, Inc. as Director and Associate Director of Strategic Planning, and an extensive background at Vertex Pharmaceuticals where roles ranged from Senior Manager to Financial Analyst in Corporate and Commercial Finance from October 2012 to July 2019. Cory began a career in finance at Freudenberg-NOK as a Financial Analyst from June 2011 to October 2012. Academic credentials include a B.S. in Finance & Accounting from the UNH Peter T. Paul College of Business and Economics, complemented by study at Corvinus University of Budapest in 2009.